SCHEMBL7313264

SCHEMBL7313264

CCNc1nc2c(s1)CC(NC(C)=O)CC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.46
CSNK2A1 P68400 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
DRD2 P14416 2/20 0.42
HRH2 P25021 2/20 0.42
DRD3 P35462 2/20 0.42
ADRB2 P07550 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
DRD4 P21917 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
HTR7 P34969 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319160 0.90 DRD3 (0.49) GSK3BCSNK2A1DRD2HRH2DRD3
SCHEMBL7325736 0.85 NPC1 (0.42) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL7312903 0.85 NPC1 (0.54) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL7319478 0.85 NPC1 (0.48) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL7324759 0.85 NPC1 (0.52) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL7322371 0.83 MAPT (0.53) GSK3BCSNK2A1NPC1RAB9A
SCHEMBL7318633 0.81 SCN3A (0.48) GSK3BCSNK2A1NPC1RAB9A
SCHEMBL1030470 0.79 GSK3B (0.55) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL1029349 0.79 GSK3B (0.55) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2
SCHEMBL12804717 0.79 GSK3B (0.55) GSK3BCSNK2A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4886812-A REGULATING DOPAMINE CONCENTRATION; PARKINSON DISEASE, HYPOTENSIVE AGENT, SCHIZOPHRENIA DR. KARL THOMAE GMBH (DE) 1989-12-12 US disclosed
US-4843086-A HYPOTENSIVE AGENTS, SCHIZOPHRENIA, PARKINSON'S DISEASE BOEHRINGER INGELHEIM KG (DE) 1989-06-27 US disclosed
US-4731374-A PARKINSON*S DISEASE DR. KARL THOMAE GMBH (DE) 1988-03-15 US disclosed
EP-0186087-A1 Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs Dr. Karl Thomae GmbH (DE) 1986-07-02 EP disclosed